Yanming Zeng

发表

Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial

Yaokai Chen, Xiao-qing He, Yihong Zhou, 2020 .

Timing of antiretroviral therapy for HIV-infected patients with cytomegalovirus retinitis: study protocol of a multi-center prospective randomized controlled trial

Yaokai Chen, Jing Yuan, Yuanyuan Qin, 2021, Trials.

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

X. He, Yaokai Chen, Vijay Harypursat, 2020, Chinese medical journal.

Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial

Yaokai Chen, Yihong Zhou, Yuanyuan Qin, 2020, Trials.

A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections

Yaokai Chen, Yuanyuan Qin, Yan-Qiu Lu, 2020, Medicine.

Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study

Hui Chen, Yaokai Chen, Yihong Zhou, 2022, BMC Pulmonary Medicine.

Comparative Effectiveness and Safety of Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients with Mild to Moderate Novel Coronavirus Pneumonia: Results of a Randomized, Open-Labeled Prospective Study

Yaokai Chen, Y. Wan, Xiao-qing He, 2020, SSRN Electronic Journal.

Independent Risk Factors for Deaths due to AIDS in Chongqing, China: Does Age Matter?

Yaokai Chen, Yihong Zhou, Yuanyuan Qin, 2021, Frontiers in Medicine.

Risk Factors for CSF/Plasma HIV-1 RNA Discordance in HIV-Infected Patients

Yaokai Chen, Yanming Zeng, Qingling Zeng, 2022, Journal of acquired immune deficiency syndromes.

Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial

Yaokai Chen, Hui Chen, Yanming Zeng, 2022, Chinese medical journal.

The development and validation of a diagnostic scoring system to differentiate pulmonary tuberculosis from non-tuberculosis pulmonary infections in HIV-infected patients with severe immune suppression

Yaokai Chen, J. Ouyang, Yaling Chen, 2021, BMC Infectious Diseases.

Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial

Ting Zhao, Yaokai Chen, Yihong Zhou, 2020, Chinese medical journal.

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized,

Yaokai Chen, Y. Wan, Vijay Harypursat, 2020, Frontiers in Pharmacology.

Development of a risk scoring system for prognostication in HIV-related toxoplasma encephalitis

Yaokai Chen, Yanming Zeng, Yao Li, 2020, BMC Infectious Diseases.

A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections

Yaokai Chen, Jing Yuan, Yinqiu Huang, 2020, Medicine.

Optimal Timing of Antiretroviral Therapy Initiation in Acquired Immunodeficiency Syndrome–Associated Toxoplasmic Encephalitis: A Prospective Observational Multicenter Study in China

Zhongsheng Jiang, Yanming Zeng, Yao Li, 2024, Infectious Diseases & Immunity.